Annexon Inc. August 2024 Corporate Presentation

Annexon is a clinical-stage biopharmaceutical company developing complement-mediated disease therapeutics targeting disorders of the body, brain, and eye. The presentation outlines the company's clinical programs, development timelines, and strategic plans for advancing product candidates toward regulatory approval and commercialization.